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Elective neck dissection versus observation in squamous cell 
carcinoma of oral cavity with clinically N0 neck: A 
systematic review and meta-analysis of prospective studies 
 
Abstract 
Purpose: To assess the possible benefits of elective neck dissection (END) in patients 
with squamous cell carcinoma (SCC) of oral cavity and clinically N0 neck. 
Methods: MEDLINE, Embase, China National Knowledge Infrastructure, and Wan 
Fang Database were systematically searched. A meta-analysis was performed to 
evaluate the possible benefits of END to such patients. 
Results: A total of 6 prospective studies involving 865 subjects fulfilled the inclusion 
criteria. The meta-analysis of all included studies revealed that END reduced the risk 
of regional recurrences significantly (RR 0.27; 95% CI 0.21-0.36) in the fixed effect 
model compared with the control, observation only. Three of the 6 included studies 
showed that the specific death rate related to regional recurrences was lower in END 
group than the observation group in the fixed effect model (RR 0.35; 95% CI 0.19-
0.65). The mean metastasis rate of occult cervical lymph node was 30.27% with the 
standard deviation (SD) of 9.42. When fixed effect model was applied, four of the 6 
included studies showed a less recurrence in END group compared with the 
observation group(RR 0.53; 95% CI 0.44-0.64). 
Conclusions: END significantly reduces the recurrences and the death related to 
regional recurrences in early-stage SCC of oral cavity with clinically N0 neck, 
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especially SCC of oral tongue and floor of mouth, which is necessary for such 
patients. 
Keywords: Oral cavity; Squamous cell carcinoma; Elective neck dissection; 
Prospective study; Meta-analysis. 
 
 
Oral cavity is one of the ten most common locations in which malignant 
tumors arise, and it occupies a quite large proportion in head and neck cancer. 
Furthermore, over 90% of them are squamous cell carcinoma (SCC).1 Cervical lymph 
node metastasis is a main reason of treatment failure, which decreases the survival 
rate significantly.2, 3 There is a consensus that neck dissection must be considered 
when apparent node metastasis is revealed clinically.4 However, in early-stage SCC of 
oral cavity, the elective management of the clinically N0 neck has been a challenge 
with controversy during the past several decades.5-7 Some researchers and clinicians 
believe that elective neck dissection (END) could avoid regional recurrences.8, 9 
Whereas, others consider END as an aggressive regime for complications, e.g. 
shoulder dysfunction, pain, and contour changes. Thus, an observation policy is 
preferred/recommanded.10-12 
Metastasis of cervical lymph nodes can occur at early-stage of SCC due to the 
fact that lymphoid tissue in head and neck region, especially the oral cavity, functions 
as a network.1, 6 25-46% of occult lymphatic metastasis in early-stage SCC of oral 
cavity has been reported.8, 13-15 However, it is difficult to make a definite diagnosis 
to occult lymphatic metastasis for a low sensitive (75%) and a general specific (81%) 
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clinical examination on the affected lymph nodes.16 Although there are many modern 
image technologies including ultrasonography, computed tomography (CT), magnetic 
resonance imaging (MRI), and positron emission tomography CT (PET-CT), the 
sensitivity in detecting such occult metastasis of cervical lymph node is not 
satisfying.17 Therefore, it is urgent to assess the necessity of END on the early-stage 
oral SCC patients with clinically N0 neck. 
We systematically reviewed all the existing prospective studies and carried out 
a meta-analysis. Five randomized controlled trials (RCTs) and one prospective 
matched case-control study were selected for the study. A total sample size of more 
than 800 were included to compare END with observation or therapeutic neck 
dissection (TND) specifically in early-stage oral SCC patients with clinically N0 neck 
to explore potential benefit of END. More rational treatment strategy acquired from 
the work may yield a better reference for surgeons. 
 
Materials and Methods 
Due to the review nature of this study, it was granted an exemption in writing 
by the institutional review board (IRB) of West China Hospital of Stomatology, 
Sichuan university. 
DATA SOURCES AND SELECTION CRITERIA 
MEDLINE via OVID (1946 to November Week 4 2017), Embase via OVID 
(1974 to December 01 2017), China National Knowledge Infrastructure (1994 to 
2017 ), and Wan Fang Database (1984 to 2017) were systematically searched. There 
were no restrictions regarding language or date of publication, yet the full text must 
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be available. Search terms were tongue, lingua, gingival, gum, cheek, bucca, palatal, 
palate, floor of mouth, retromolar region, lip, labia, mouth, oral, cancer, carcinoma, 
neoplasm, tumor, tumour, squamous cell carcinoma, SCC, neck dissection, and 
cervical lymphadenectomy. 
All of the prospective studies comparing END with observation or TND were 
included in this systematic review for further meta-analysis. All patients were 
confirmed pathologically as SCC of oral cavity without clinically apparent metastasis 
of cervical lymph node or distant metastases at the time of diagnosis. In addition, the 
patients had not received any anti-tumor treatment before. The management for the 
primary tumor was surgery or radiotherapy. Close observation was offered to patients 
with clinically N0 neck, TND was performed only when cervical lymph node 
metastasis was confirmed or highly suspected. The minimum of follow-up was 9 
months.  
Exclusion criteria were as follows: The outcomes of interest were not 
available or not well-defined. Two reviewers independently searched and assessed 
abstracts and full texts. Disagreements were resolved by consensus. 
QUALITY ASSESSMENT 
A Risk of Bias table recommended by the Cochrane Handbook for Systematic 
Reviews of Interventions (www.cochrane-handbook.org) was used to assess the 
quality of included studies, which contains seven aspects of risk of bias: random 
sequence generation, allocation concealment, blinding of participants and personnel, 
blinding of outcome assessment, incomplete outcome data, selective reporting, and 
other biases. Each aspect was rated as low, high or unclear risk of bias. Studies were 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
assessed by two independent reviewers using the Risk of Bias table. Any 
disagreement was resolved by discussion. 
DATA EXTRACTION 
Information about study design, year of accrual, sample size, patient 
characteristics (age and gender), tumor site, T-stage distribution, primary tumor 
treatment, and follow-up time were extracted (Table 1, Table 2). In addition, data of 
all the outcomes were also extracted. The first reviewer extracted these data from the 
original published work and imported them into pre-designed data forms. The second 
reviewer checked the extracted data. Then both reviewers discussed on any different  
opinion, and agreements were achieved by consensus. Four parameters were chosen 
as the end points for the systematic review and  meta-analysis, which were regional 
recurrences (cervical lymph node metastasis), the specific death rate related to 
regional recurrences, occult cervical lymph node metastasis, and total number of 
recurrences (Table 3). The first two parameters were regarded as primary outcomes. 
An attempt was made to contact the authors for relevant information that were not 
revealed or clear. 
STATISTICAL ANALYSIS 
Statistical analysis was performed using RevMan (Version 5.3. Copenhagen: 
The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). Risk ratios (RR) of 
regional recurrences, the specific death rate related to regional recurrences, and total 
number of recurrences were calculated with respective 95% confidence intervals (CI) 
for each study. The specific death related to regional recurrences was defined as the 
death of diseases (metastasis or recurrence) of  cervical lymph node, and the total 
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number of recurrences was defined as any recurrence such as local recurrence, 
regional recurrence, and distant metastasis. 
The level of statistical heterogeneity among included studies was determined 
by Chi-squared distributed Q statistic and I2 statistic, and P＜0.05 was defined as 
statistically significant. When heterogeneity was low level (P＞0.05, I2 <50%), a 
fixed effect model was used, and when heterogeneity was high level (P＜0.05, 
I2 >50%), a random effect model was used. Forest plots were used to display the 
results of all outcomes. The biases of publications were assessed by Begg's test and 
Egger's test, and sensitivity analyses were performed by Stata (Version 12.0). 
 
Results 
LITERATURE SEARCH RESULTS 
The search strategy yielded 5638 articles from MEDLINE and Embase 
databases and 66 articles from Chinese databases after removal of duplicates. Six 
prospective studies (5 RCTs and 1 prospective randomized matched case-control 
study) satisfied the inclusion criteria (Figure 1).18-23 A total of 865 patients were 
involved. Except for the study reported by Yuen et al,23 the rest were single-center 
studies. 
METHODOLOGICAL QUALITY 
The quality of each study was assessed by the Risk of Bias table. Evaluation 
were illustrated in Table 4. In review of the seven aspects of bias, studies done by 
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Vandenbrouck et al,20 D’Cruz et al22 and Yuen et al23 showed a relative higher design 
quality, and the design quality of the another three studies were moderate.  
REGIONAL RECURRENCES 
All six studies reported the outcomes of regional recurrences. All of them 
showed that the regional recurrences in END group was significantly less than the 
observation and TND groups. The heterogeneity level of regional recurrences across 
studies was low (I2 = 19%; P＝0.29 ); therefore ,a fixed effect model was employed. 
Further, meta-analysis revealed that END reduced the risk of regional recurrences 
significantly (RR 0.27; 95% CI 0.21-0.36) (Figure 2a). There was no publication bias 
in this outcome (Pr>|z|=0.260>0.05, P>|t|=0.534>0.05). The sensitivity analysis 
indicated that the results were relatively stable (Figure 2b). 
THE SPECIFIC DEATH RATE RELATED TO REGIONAL RECURRENCES 
Four studies reported the specific death rate related to regional recurrences, 
however only three studies could be synthesized for analysis. Compared with 
observation or TND group, END group showed lower specific death rates related to 
regional recurrences. Only one study that was done by Mirea et al displayed a 
statistical significance.18 The data from the three studies held minimal heterogeneity 
(I2 = 0%; P＝0.45) and were analyzed by a fixed effect model (RR 0.35; 95% CI 
0.19-0.65). The three studies yielded significant pooled findings that the specific 
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death rate related to regional recurrences was lower in END group compared with 
observation and TND groups (Figure 3a). Neither Begg's test nor Egger's test 
demonstrated any publication bias (Pr>|z|=1.000>0.05, P>|t|=0.604>0.05). The 
sensitivity analysis verified the stability of the results (Figure 3b). 
OCCULT CERVICAL LYMPH NODE METASTASIS 
Occult cervical lymph node metastasis in END group was investigated in all 
six studies. The rates of occult metastasis ranged from 20.59 to 49% with the mean of 
30.27% and the standard deviation (SD) of 9.42 (Table 5). 
TOTAL NUMBER OF RECURRENCES 
Four studies reported the total number of recurrences, which could be pooled 
in meta-analysis. Four studies revealed less total number of recurrences in END group 
when compared with observation and TND groups. Study done by Kligerman et al21 
showed no statistical significance. Due to the minimal heterogeneity (I2 = 0%; P＝
0.44), a fixed effect model was used. On meta-analysis of these four studies, END 
group had less total number of recurrences (RR 0.53; 95% CI 0.44-0.64) (Figure 4a). 
There was no evidence of publication bias using Begg's test and Egger's test 
(Pr>|z|=0.734>0.05, P>|t|=0.176>0.05). The stability of results was acceptable as 
shown in Figure 4b. 
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Discussion 
Tongue, floor of mouth, and buccal mucosa are the most common three sites 
that oral SCC occurs.24 Thus, the studies included in this meta-analysis investigated 
oral SCC arising in these sites. The metastasis rate of cervical lymph node of oral 
SCC is high, which affects the survival rate significantly.3, 25 Furthermore, occult 
metastasis may exist in early-stage oral SCC. The conventional/classic  treatment of 
primary tumor is surgery; however, radiotherapy has also demonstrated a satisfactory 
outcome similar to surgery in T1/T2 cases, besides, some studies have indicated that 
five-year survival rates in early stage (I and II) oral SCC treated with either surgery or 
radiotherapy are similar.26-30 Therefore, the study reported by Vandenbrouck et al20 
where radiotherapy was applied to treat oral SCC has been included in the systematic 
review. The six prospective studies that met the selection criteria were pooled in the 
meta-analysis to investigate the necessity of END for oral SCC patients with clinically 
N0 neck. 
Fasunla et al31 and Ren et al32 conducted meta-analyses of four and five RCTs 
respectively in 2011 and 2015. Both demonstrated the need to perform END in oral 
cancers with clinically N0 neck. However, the number of studies included in these 
meta-analyses were small. From the results of current meta-analysis on primary 
outcomes, it was obvious that END significantly reduced the risk of regional 
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recurrence and the specific death rate with RR of 0.27 and 0.35, respectively. 
Although two studies19, 20 did not reveal statistical significance in the specific death 
rate related to regional recurrences, the synthetic result indicated a statistical 
significance. Previous studies reported a lower disease-specific death rate in END 
group compared with observation or TND group.23, 33 However, there is no 
explanation about the relationship between the death and regional recurrence. None of 
the three previous meta-analyses paid attention to the outcome.31, 32, 34 The present 
meta-analysis indicated that regional recurrence might be the main cause of disease-
specific death. Hence, regional control (management of neck) must have a positive 
impact on survival rate. Besides, END is a feasible strategy to achieve a satisfactory 
regional control. 
The mean rate of occult metastasis in END group was 30.27% based on all six 
studies, which coincided with other reports.8, 13-15 It is logic to conclude that one third 
of early-stage oral SCC patients with clinically N0 neck are exposed to the risk of 
regional recurrence or metastasis. Researchers/clinicians put forward a threshold of a 
15% possibility of cervical metastasis as the indication for END in SCC of head and 
neck.35 Based on above all, END should be considered in order to prevent regional 
recurrence or metastasis from happening. In addition, the meta-analysis showed that  
the total number of recurrences in END group was less than observation and TND 
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groups significantly (RR 0.53; 95% CI 0.44-0.64), which implies that END may 
reduce other type of recurrence apart from regional recurrence. Yet the specific 
reasons require further investigation. 
Although not all outcomes were pooled into the meta-analysis,  some 
outcomes that were reported in these studies have unveiled more information. Fakih et 
al19 reported the development of cervical lymph node metastasis was significantly 
related to the tumor depth. They found that 92% (11/12) patient with a tumor depth of 
less than 4 mm had uninvolved node, whereas 33% (3/9) patients with a tumor depth 
of greater than 4 mm had uninvolved node (P<0.01). Moreover in the observation 
group, 78% of patients (tumor depth＜4mm) and  24% of patients (tumor depth＞
4mm) did not develop any neck node (P <0.01). The results indicated that tumor 
depth influences the prognosis of oral SCC, which is in agreement with recent 
researches.36, 37 The American Joint Committee on Cancer (AJCC) and the 
International Union Against Cancer (UICC) have recently included the depth of 
invasion (DOI) as a new important prognostic factor, and updated the Cancer Staging 
Manual of the lip and oral cavity (8th edition, October 2016). In this new staging 
system, 5 mm and 10 mm of DOI are determined as standards to decide T-stage of the 
tumor.  
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One of the included studies by Vandenbrouck et al20 demonstrated that the 
node capsular rupture rate of END group was significant different from that of the 
TND group (13 versus 30%, P <0.05). It is generally agreed that extranodal extension 
(ENE) is a vital factor affecting the prognosis.38-40 Naturally, we would recommend 
that END benefits prognosis of early-stage oral SCC with clinically N0 neck over 
TND. It is worth mentioning that N-stage is another important update of Cancer 
Staging Manual of the lip and oral cavity (8th edition, 2016). Any lymph node with 
ENE (+) will be recognized as N3b. 
As reported in literature, there are varying degrees of risk for nodal 
involvement for tumors appearing on different sites within the oral cavity, moreover, 
cancers of oral tongue and floor of mouth are the most likely to metastasize to 
cervical lymph nodes.41, 42 Among the all studies included in this meta-analysis, the 
majority of subjects are SCC of oral tongue or floor of mouth, the present conclusions 
thus apply essentially to these tumors with high risk of nodal metastasis. There is only 
one study by D’Cruz et al22 including SCC of buccal mucosa which accounted for a 
low percentage of 13.7%, in contrast, SCC of oral tongue accounted for a high 
percentage of 85.28%. Therefore, the authors considered that their conclusions were 
most applicable to SCC of oral tongue. Unfortunately, subgroup analysis could not be 
conducted in the present meta-analysis for the fact that these parameters included in it 
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were not reported respectively according to different tumor sites. Surprisingly, the 
results of the study with high quality and large sample size indicated that the depth of 
tumor invasion was the main factor significantly associated with node involvement. In 
other words, tumor site did not make difference in node positivity. Besides, sensitivity 
analysis was conducted in the present meta-analysis by removing the study including 
SCC of buccal mucosa, and the stability was confirmed. Similarly, the study by 
Kligerman et al21 containing SCC of oral tongue and floor of mouth also 
demonstrated that there were no significant differences in occult nodal metastasis 
between the two oral cancers; additionally, the stage and tumor thickness were 
regarded as factors affecting prognosis significantly. More importantly, the result of 
sensitivity analysis to this study was also acceptable. Hence, the conclusions drawn 
from the present systematic review are applicable to SCC of oral tongue and floor of 
mouth, and notably further studies are required to substantiate these findings. 
Unfortunately, there are still some limitations in this systematic review. First, 
the number of included studies and the sample sizes were limited. Second, some 
included studies were antiquated. For example, study from Vandenbrouck et al20  was 
published almost 40 years ago. The diagnosis tools  and level of treatment  were 
undoubtedly different from that of the present, which undervalued the comparison 
power. Third, not all information were reported consistently in every study. In other 
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words, some outcomes could not be synthesized in current meta-analysis. Fourth, the 
included studies only investigated oral SCC involving oral tongue, floor of mouth , 
and buccal mucosa. There is no valid evidence that END benefits the oral SCC of 
other sites. Therefore, more multicenter studies on large sample size with holistic 
information are required to verify the conclusions and extend them to other aspects. 
Moreover, there is a need to develop a much simpler, more precise and economic 
clinical examination method to detect the occult metastasis of cervical lymph nodes. 
In conclusion, this systematic review and meta-analysis suggest that END 
significantly reduces the regional recurrences and the death related to it in early-stage 
oral SCC with clinically N0 neck, especially SCC of oral tongue and floor of mouth, 
confirming the necessity of  END for these patients.   
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Table 1. CHARACTERISTICS OF THE INCLUDED STUDIES (PART 1) 
Study Design Year of 
accrual 
Sample 
size 
Age (years) Gender 
(M/F) 
Site 
Mirea18 2014 
(Romania) 
prospective 
randomized 
matched case-
control study 
 
2000.1-
2005.1 
86 Mean: 54 69/17  A  
Fakih19 1989 
(India) 
prospective, 
randomized 
trial 
 
1985.7-
1988.9 
70  NA  45/25  AT 
Vandenbrouck20  
1980 (France) 
randomized 
trial 
 
1966.12-
1973.7 
75 Mean: 57 
 
67/8 
 
AT, 
FM 
Kligerman21 1994 
(Brazil) 
prospective, 
randomized 
study 
1987-
1992 
67 Median: 57 52/15 AT, 
FM 
D’Cruz22 2015 
(India) 
prospective, 
randomized, 
controlled trial 
2004.1-
2014.6 
496 Mean: 48 374/122 AT, 
BM, 
FM 
Yuen23 2009 
(Hong Kong) 
prospective 
randomized 
study 
1996-
2004 
71 Mean: 57 43/28 AT 
Abbreviations: NA, not available; M, male; F, female; AT, oral tongue (anterior two third of 
the tongue); BM, buccal mucosa; FM, floor of the mouth. 
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Table 2. CHARACTERISTICS OF THE INCLUDED STUDIES (PART 2) 
Study T-stage distribution 
(T1/T2/T3) 
Stratification Lymph 
nodes 
examination 
Primary 
tumor 
treatment 
Follow-up 
time 
(months) 
Mirea18 2014 
(Romania) 
SND+: 20/28 
SND-: NA 
By age and sex palpation, 
CT  
operation Mean: 90.5 
 
Fakih19 1989 
(India) 
24/46 No NA operation Median: 20  
Vandenbrouck20  
1980 (France) 
15/48/10 No NA radiotherapy 60 
Kligerman21 1994 
(Brazil) 
31/36 By stage NA operation 42 
D’Cruz22 2015 
(India) 
219/277 By tumor site, 
stage, sex, and 
ultrasound 
findings 
physical 
examination,  
ultrasound 
operation Median: 39 
 
Yuen23 2009 
(Hong Kong) 
43/28 By stage clinical 
examination, 
ultrasound, 
aspiration 
operation Mean: 86  
Abbreviations: CT, computed tomography; NA, not available. 
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Table 3. DATA OF REGIONAL RECURRENCES, THE SPECIFIC DEATH RATE 
RELATED TO REGIONAL RECURRENCES, OCCULT CERVICAL LYMPH NODE 
METASTASIS, AND TOTAL NUMBER OF RECURRENCES OF THE INCLUDED 
STUDIES 
Study Outcome 1* Outcome 2† Outcome 3‡ Outcome 4§ 
Mirea 201418 END+: 8.33% (4/48) 
END-: 39.47% (15/38) 
END+: 6.25% (3/48) 
END-: 31.6% (12/38) 
27.08% (13/48) 
T1: 20% (4/20) 
T2: 32.14% (9/28) 
 
END+: 16.67% (8/48) 
END-: 47.37% (18/38) 
Fakih 198919 END+: 30% (9/30) 
END-: 57.5% (23/40) 
END+: 20% (6/30) 
END-: 40% (16/40) 
33.33% (10/30) 
 
 
NA 
Vandenbrouck 
198020 
END: 7.69% (3/39) 
TND: 47% (17/36) 
END: 5.13% (2/39) 
TND: 13.89% (5/36) 
49% (19/39) 
 
 
NA 
Kligerman 199421 END+: 12% (4/34) 
END-: 39% (13/33) 
NA 20.59% (7/34) 
AT: 26% (6/23) 
FM: 9% (1/11) 
 
END+: 24% (8/34) 
END-: 42% (14/33) 
D’Cruz 201522 END: 11.93% (29/243) 
TND: 45.05% (114/253) 
END: NA 
TND: 23.72% (60/253) 
29.63% (72/243) 
 
 
END: 33.3% (81/243) 
TND: 57.7% (146/253) 
Yuen 200923 END+: 5.56% (2/36)  
END-: 37.14% (13/35) 
END+: 0 
END-: 0 
22% (8/36) 
 
END+: 16.67% (6/36) 
END-: 45.71% (16/35) 
Abbreviations: NA, not available; END, elective neck dissection; TND, therapeutic neck 
dissection; AT, oral tongue; FM, floor of the mouth. 
* regional recurrences; † the specific death rate related to regional recurrences; ‡ occult cervical 
lymph node metastasis; § total number of recurrences 
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Table 4. RISK OF BIAS OF THE INCLUDED STUDIES 
Study Aspect 1* Aspect 2† Aspect 3‡ Aspect 4§ Aspect 5ǁ Aspect 6¶ Aspect 7# 
Mirea 201418 LR LR UR UR LR LR LR 
Fakih 198919 LR UR UR UR LR LR LR 
Vandenbrouck 198020 LR LR UR LR LR LR LR 
Kligerman 199421 LR UR UR UR LR LR LR 
D’Cruz 201522 LR LR UR LR LR LR LR 
Yuen 200923 LR LR LR LR LR LR LR 
Abbreviations: LR, low risk; UR, unclear risk. 
* random sequence generation; † allocation concealment; ‡ blinding of participants and 
personnel; § blinding of outcome assessment; ǁ incomplete outcome data; ¶ selective reporting; 
# other bias. 
 
 
Table 5. THE RATES OF OCCULT CERVICAL LYMPH NODE METASTASIS OF 
THE INCLUDED STUDIES 
 Rate of occult cervical nodal metastasis 
Mirea 201418 27.08% 
Fakih 198919 33.33% 
Vandenbrouck 198020 49% 
Kligerman 199421 20.59% 
D’Cruz 201522 29.63% 
Yuen 200923 22% 
Mean 30.27% 
SD 9.42 
Abbreviations: SD, standard deviation. 
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FIGURE 1. Flow diagram of selection for the study. 
FIGURE 2. a, Forest plot of regional recurrences (I2 = 19%, P＝0.29; RR 0.27, 95% CI 0.21-
0.36). b, Sensitivity analyses of regional recurrences. 
FIGURE 3. a, Forest plot of the specific death rate related to regional recurrences (I2 = 0%, P
＝0.45; RR 0.35, 95% CI 0.19-0.65). b, Sensitivity analyses of the specific death rate related 
to regional recurrences. 
FIGURE 4. a, Forest plot of total number of recurrences (I2 = 0%, P＝0.44; RR 0.53, 95% CI 
0.44-0.64). b, Sensitivity analyses of total number of recurrences. 
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